Outsource development and testing of your cancer drugs in 3D InSight™ Tumor Microtissue models that better reflect complex tumor biology.
- Leverage physiologically relevant 3D tumor co-cultures composed of tumor, stromal and immune components
- Gain greater translational insight testing in cell line, PDX-derived tumor microtissues
- Assess single agent or combinatorial efficacy of small molecule, biological, ADC or immunomodulatory drugs using 3D optimized endpoints
- Develop a detailed study plan with our 3D experts, then receive rapid turnaround with comprehensive reporting and analysis
Custom Tumor Model Development
Build a model with tumor and stromal components derived from cell line, PDX, or primary patient material.